Elodie Hainque Selected Research

Deep Brain Stimulation

2/2024	The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study.
10/2023	Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson's disease.
11/2022	Freezing of gait depends on cortico-subthalamic network recruitment following STN-DBS in PD patients.
1/2022	Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson's Disease (PSYCHO-STIM II).
11/2021	Preoperative REM Sleep Behavior Disorder and Subthalamic Nucleus Deep Brain Stimulation Outcome in Parkinson Disease 1 Year After Surgery.
1/2021	Whispering dysphonia in TUBB4A-related disorders responsive to bipallidal deep brain stimulation.
1/2021	Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective Study.
1/2019	Long-term GPi-DBS improves motor features in myoclonus-dystonia and enhances social adjustment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elodie Hainque Research Topics

Disease

9	Parkinson Disease (Parkinson's Disease) 02/2024 - 10/2010
4	Glut1 Deficiency Syndrome 01/2020 - 05/2016
2	Movement Disorders (Movement Disorder) 11/2021 - 07/2017
2	Dystonia (Limb Dystonia) 01/2021 - 05/2016
2	Myoclonic dystonia 01/2019 - 05/2016
1	REM Sleep Behavior Disorder 11/2021
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2021
1	Dysphonia (Spastic Dysphonia) 01/2021
1	Alternating hemiplegia of childhood 10/2017
1	Tremor (Tremors) 10/2017
1	Epilepsy (Aura) 07/2017
1	Myoclonus (Nocturnal Myoclonus) 05/2016
1	Gambling (Pathological Gambling) 10/2010

Drug/Important Bio-Agent (IBA)

4	triheptanoinIBA 01/2020 - 05/2016
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 10/2010
1	Dihydroxyphenylalanine (Dopa)IBA 01/2022
1	Apomorphine FDA Link 06/2021
1	Sarcoglycans (beta Sarcoglycan)IBA 01/2019
1	TabletsIBA 10/2017
1	Glucose Transporter Type 1IBA 07/2017
1	Zonisamide (Zonegran)FDA LinkGeneric 05/2016
1	Therapeutic UsesIBA 05/2016

Therapy/Procedure

8	Deep Brain Stimulation 02/2024 - 01/2019
3	Ketogenic Diet 01/2020 - 05/2016
1	Activities of Daily Living (ADL) 11/2021